| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 09/02/2004 | WO2004074468A1 Novel pectinases and uses thereof |
| 09/02/2004 | WO2004074461A2 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | WO2004074459A2 Pten-deficient cells and their uses |
| 09/02/2004 | WO2004074458A2 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 09/02/2004 | WO2004074453A2 Kinases and phosphatases |
| 09/02/2004 | WO2004074445A2 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/02/2004 | WO2004074443A2 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps) |
| 09/02/2004 | WO2004074311A2 Human cyclooxygenase-3 and uses thereof |
| 09/02/2004 | WO2004074301A2 Differentially expressed nucleic acids that correlate with ksp expression |
| 09/02/2004 | WO2004073734A1 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation |
| 09/02/2004 | WO2004073640A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | WO2004073622A2 Novel therapeutic method and compositions for topical administration |
| 09/02/2004 | WO2004073604A2 Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity |
| 09/02/2004 | WO2004073603A2 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity |
| 09/02/2004 | WO2004061422A3 Bindingzyme arrays and high-throughput proteomic methods |
| 09/02/2004 | WO2004058934A3 Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content |
| 09/02/2004 | WO2004056968A3 Generation of plants with altered oil content |
| 09/02/2004 | WO2004053135A3 Expression cassette encoding a hydroxyphenylpyruvate dioxygenase and herbicide-tolerant plants containing such a gene |
| 09/02/2004 | WO2004048517A3 Method for reducing or preventing modification of a polypeptide in solution |
| 09/02/2004 | WO2004036979A3 Production of vanillin in microbial cells |
| 09/02/2004 | WO2004016212A3 Methods and compositions for targeting secretory lysosomes |
| 09/02/2004 | WO2003093425A3 Methods of identifying genes for the manipulation of triterpene saponins |
| 09/02/2004 | US20040172689 Recombination polypeptide for use as gene insertion tool during genic transfer; tissue engineering and the generaton of disease resistant plants |
| 09/02/2004 | US20040172687 Modified proteinase inhibitors |
| 09/02/2004 | US20040172685 Method of using MAPK4 and orthologues thereof to control plant disease resistance and plant growth |
| 09/02/2004 | US20040172682 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 09/02/2004 | US20040172681 Trangenic plant with enhanced phosphopantetheine:protein transferase and fatty acid sythase activity for increasing concentration of oils in plant tissue; tissue engineering |
| 09/02/2004 | US20040172680 Process for modifying plants |
| 09/02/2004 | US20040172679 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/02/2004 | US20040172677 Transgenic peas, tomatoes or beans comprising vector coding nucleotide sequences associated with glutamate glyoxylate aminotransferase activity for use in generating plants with enhanced gluamate concentrations |
| 09/02/2004 | US20040172674 Expression vector comprising nucleotide sequences coding enzymatic polypeptide associated with phenylpropanoid biosynthesis pathway for enhancing isoflavone content in seeds of transgenic plants |
| 09/02/2004 | US20040172665 Compositions and methods for treating enzyme deficiency |
| 09/02/2004 | US20040171826 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 09/02/2004 | US20040171822 Methods for determining ring number in carotenoids by lycopene epsilon-cyclasses and uses thereof |
| 09/02/2004 | US20040171565 vaccines that express derivatives of ADP-ribosyltransferase toxins that display significantly reduced, or are deficient in, intrinsic ADP-ribosyltransferase activity (i.e. herein referred to as mARTs) and yet retain adjuvanticity |
| 09/02/2004 | US20040171555 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 09/02/2004 | US20040171549 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 09/02/2004 | US20040171547 inhibiting the growth of a cancerous cell by contacting cell with an effective amount of a RhoB protein, or a variant of the RhoB protein; alone or in combination with additional anti-cancer agents, such as cytotoxic agents (e.g., 5-flurouracil) |
| 09/02/2004 | US20040171539 Regulation of human protein kinase-like protein |
| 09/02/2004 | US20040171535 Heparanase II, a novel human heparanase paralog |
| 09/02/2004 | US20040171157 Recombinational cloning using nucleic acids having recombination sites |
| 09/02/2004 | US20040171156 for moving or exchanging segments of DNA molecules using proteins to provide chimeric DNA molecules in vitro and in vivo |
| 09/02/2004 | US20040171155 Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 09/02/2004 | US20040171133 Transgenic microorganism comprising defective acyltransferase nucleotide sequences and reduced lipooligosaccharide (LOS) concentrations in membranes for prevention, diagnosis and treatment of meningococcal infections; genetic vaccines |
| 09/02/2004 | US20040171131 Nucleotide sequences coding enzymatic polypeptide associated with tubulin tyrosination for diagnosing, preventing and treating cell proliferative, gastrointestinal and reproductive disorders; antitumor agents |
| 09/02/2004 | US20040171130 Comprises polypeptide associated with pentose phosphate pathway for use in preparation of amino acids for use in cosmetics, foods and pharmeceuticals |
| 09/02/2004 | US20040171125 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171119 Reductase gene and use of the same |
| 09/02/2004 | US20040171110 Novel member of the lysyl oxidase gene family |
| 09/02/2004 | US20040171106 Process for producing dipeptides |
| 09/02/2004 | US20040171105 Using enzymatic polypeptide to inactivate inhibitor of apoptosis and activate caspase for treatment and prevention of cancer, autoimmune and neurodegenerative diseases |
| 09/02/2004 | US20040171104 may be used in food related applications to improve flavor, such as baking; genetic engineering |
| 09/02/2004 | US20040171103 Process for the production of a reversibly inactive acidified plasmin composition |
| 09/02/2004 | US20040171099 Using luciferin derivatives for analyzing metabolic activity in animals, cells or in cell-free reaction formulations |
| 09/02/2004 | US20040171098 Signalling compounds for use in methods of detecting hydrogen peroxide |
| 09/02/2004 | US20040171096 Using lipid phosphates activity profile as diagnostic tool for detection and treatment of cancer; pregnancy determination; kits |
| 09/02/2004 | US20040171074 Structures of substrate binding pockets of SCF complexes |
| 09/02/2004 | US20040171062 microarrays for drug screening; X-ray crystallography/co-crystal analysis; combinatorial chemistry |
| 09/02/2004 | US20040171059 Comprises nucleotide sequences coding enzymatic polypeptide associated with programed cell death for identifying modulators for treatment of inflammatory, neurodegenerative and cell proliferative disorders |
| 09/02/2004 | US20040171050 Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
| 09/02/2004 | US20040171041 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences |
| 09/02/2004 | US20040171037 Using genic copy number of oncogenes to diagnose, prevent and treat tumor disorders; antitumor agents |
| 09/02/2004 | US20040171033 Comprises modified nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents |
| 09/02/2004 | US20040171031 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 09/02/2004 | US20040171030 Oligonucleotide sequences capable of binding RNA-induced silencing complexes for use in treatment and prevention of metabolic and cell proliferative disorders |
| 09/02/2004 | US20040171023 Utilization of starch for biological production by fermentation |
| 09/02/2004 | US20040171019 Comprises nucleotide sequences coding isomerase which catalyzes rotation about proline residues for identifying modulators and designing treatments for cell proliferative disorders |
| 09/02/2004 | US20040171009 Lipid-associated molecules |
| 09/02/2004 | US20040171006 Comprises nucleotide sequences coding enzymatic polypeptide treatment and prevention of cancers, nervous system, urogenital, hematological and gastro-intestinal disorders |
| 09/02/2004 | US20040171000 Comprises nucleotide sequences coding yeast telomerase subunit (EST-1) for identifying modulators for prevention and tredatment of cell proliferative and aging related disorders |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170987 Polynucleotides encoding polypeptides involved in intermediates metabolism of central metabolic pathway in methylophilus methylotrophus |
| 09/02/2004 | US20040170986 Polynucleotides encoding polypeptides involved in amino acid biosynthesis in methylophilus methylotrophus |
| 09/02/2004 | US20040170985 Polynucleotides encoding polypeptides involved in the stress response to environmental changes in methylophilus methylotrophus |
| 09/02/2004 | US20040170980 Molecules capable of binding to telomere and the like and method with the use of the same |
| 09/02/2004 | US20040170979 Dna encoding l-ribose isomerase and uses thereof |
| 09/02/2004 | US20040170974 for drug screening treatments for asthma/inflammatory disorders; genetic engineering; kits |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170972 comprises DNA vaccine, a recombinant vaccine, and a T cell epitope vaccine; includes use of serological diagnosis; genetic engineering |
| 09/02/2004 | US20040170970 Split- ubiquitin based reporter systems and methods of their use |
| 09/02/2004 | US20040170631 Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies |
| 09/02/2004 | US20040170619 contacting a nucleic acid binding polypeptide, preferably a zinc finger polypeptide, with a nucleic acid sequence in the primary cell to regulate its expression; |
| 09/02/2004 | US20040170618 antagonists bind to a recognized target (e.g., a receptor); the enzyme component of the chimera then degrades the target resulting in a reduction of activity of the target and release of the chimeric molecule, which is then free to attack and degrade another target molecule. |
| 09/02/2004 | US20040170616 transferring a gene to preselected vertebrate cells by accelerating microprojectiles carrying polynucleic acid sequences having a regulatory sequence in the 5' to 3' direction and a gene downstream from the sequence at the cells to penetrate them and deposit the polynucleic acid sequences therein. |
| 09/02/2004 | DE102004006526A1 Neues Lysindecarboxylase-Gen und Verfahren zur Herstellung von L-Lysin New lysine decarboxylase gene, and methods for producing L-lysine |
| 09/02/2004 | CA2824150A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2824126A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2753408A1 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | CA2731504A1 Combinatorial dna library for producing modified n-glycans in lower eukaryotes |
| 09/02/2004 | CA2516777A1 Human cyclooxygenase-3 enzyme and uses thereof |
| 09/02/2004 | CA2516550A1 Production of modified glycoproteins having multiple antennary structures |
| 09/02/2004 | CA2516544A1 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
| 09/02/2004 | CA2516527A1 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 09/02/2004 | CA2516520A1 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
| 09/02/2004 | CA2516440A1 Combinatorial dna library for producing modified n-glycans in lower eukaryotes |
| 09/02/2004 | CA2516282A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 09/02/2004 | CA2516221A1 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps) |
| 09/02/2004 | CA2516029A1 Method of measuring homocysteine |
| 09/02/2004 | CA2515965A1 Inhibition of tace or amphiregulin for the modulation of egf receptor signal transactivation |